BRPI0715051A2 - Processo e intermediários para a síntese de derivados de 2-(quinolin-5il)-4,5 dissubstituído-azol - Google Patents

Processo e intermediários para a síntese de derivados de 2-(quinolin-5il)-4,5 dissubstituído-azol

Info

Publication number
BRPI0715051A2
BRPI0715051A2 BRPI0715051-2A BRPI0715051A BRPI0715051A2 BR PI0715051 A2 BRPI0715051 A2 BR PI0715051A2 BR PI0715051 A BRPI0715051 A BR PI0715051A BR PI0715051 A2 BRPI0715051 A2 BR PI0715051A2
Authority
BR
Brazil
Prior art keywords
quinolin
disubstituted
intermediates
synthesis
azole derivatives
Prior art date
Application number
BRPI0715051-2A
Other languages
English (en)
Inventor
Timothy D Cutarelli
Xiaoyong Fu
Timothy L Mcallister
Michael R Reeder
Jianguo Yin
Kelvin H Yong
Shuyi Zhang
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BRPI0715051A2 publication Critical patent/BRPI0715051A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0715051-2A 2006-08-14 2007-08-10 Processo e intermediários para a síntese de derivados de 2-(quinolin-5il)-4,5 dissubstituído-azol BRPI0715051A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83756706P 2006-08-14 2006-08-14
US95925207P 2007-07-10 2007-07-10
PCT/US2007/017796 WO2008021235A2 (en) 2006-08-14 2007-08-10 Process and intermediates for the synthesis of 2-(quinolin-5-yl)-4,5 disubstituted-azole derivatives

Publications (1)

Publication Number Publication Date
BRPI0715051A2 true BRPI0715051A2 (pt) 2015-05-19

Family

ID=38787609

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0715051-2A BRPI0715051A2 (pt) 2006-08-14 2007-08-10 Processo e intermediários para a síntese de derivados de 2-(quinolin-5il)-4,5 dissubstituído-azol

Country Status (12)

Country Link
US (1) US7985860B2 (pt)
EP (3) EP2385050A1 (pt)
JP (1) JP2010500405A (pt)
KR (1) KR20090040378A (pt)
AR (1) AR062361A1 (pt)
AU (1) AU2007284688A1 (pt)
BR (1) BRPI0715051A2 (pt)
CA (1) CA2660736A1 (pt)
CO (1) CO6160220A2 (pt)
MX (1) MX2009001767A (pt)
NO (1) NO20091095L (pt)
WO (1) WO2008021235A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9029411B2 (en) 2008-01-25 2015-05-12 Millennium Pharmaceuticals, Inc. Thiophenes and uses thereof
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2010090716A1 (en) 2009-01-30 2010-08-12 Millennium Pharmaceuticals, Inc. Heteroaryls and their use as pi3k inhibitors
US9090601B2 (en) 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
WO2012021611A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
TW201217365A (en) 2010-08-11 2012-05-01 Millennium Pharm Inc Heteroaryls and uses thereof
US8859768B2 (en) 2010-08-11 2014-10-14 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
TW201307309A (zh) 2010-10-13 2013-02-16 Millennium Pharm Inc 雜芳基化合物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2565599C (en) * 2004-05-18 2012-07-31 Schering Corporation Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
CA2657902A1 (en) * 2006-07-11 2008-01-17 Schering Corporation Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound

Also Published As

Publication number Publication date
WO2008021235A2 (en) 2008-02-21
CA2660736A1 (en) 2008-02-21
JP2010500405A (ja) 2010-01-07
US7985860B2 (en) 2011-07-26
NO20091095L (no) 2009-05-12
US20080045718A1 (en) 2008-02-21
EP2385051A1 (en) 2011-11-09
AR062361A1 (es) 2008-11-05
WO2008021235A3 (en) 2008-08-07
AU2007284688A1 (en) 2008-02-21
EP2069284A2 (en) 2009-06-17
CO6160220A2 (es) 2010-05-20
EP2385050A1 (en) 2011-11-09
MX2009001767A (es) 2009-02-25
KR20090040378A (ko) 2009-04-23

Similar Documents

Publication Publication Date Title
BRPI0715051A2 (pt) Processo e intermediários para a síntese de derivados de 2-(quinolin-5il)-4,5 dissubstituído-azol
EP2070633A4 (en) LASER PROCESSING PROCEDURES
ES2380489T8 (es) Proceso para la síntesis de compuestos orgánicos
PT2351578T (pt) Processo para o fabrico de vacinas
IT1392456B1 (it) Processo per la sintesi di di- o oligosaccaridi l-fucosilati e loro nuovi intermedi 2,3,4-tribenzil-fucosil-derivati.
BRPI0817909A2 (pt) Intermediários e métodos para a síntese de análogos de halicondrina
BRPI0719955A2 (pt) Processo para síntese de derivados de fenóxi diaminopirimidina
PL3239145T3 (pl) Pochodne 1-[2-[3,5-podstawionego-1h-pirazol-1-ylo]acetylo]-4-piperydyno-karbonitrylu i -karbotiamidu jako związki pośrednie do wytwarzania fungicydów do ochrony roślin uprawnych
EP1976511A4 (en) FLUORATED ARYLAMIDE DERIVATIVES
CR10733A (es) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
BRPI0814995A2 (pt) Métodos para a síntese de olefinas e derivados
BRPI0915571A2 (pt) processo para à fabricação de um 1,2-epóxido
BRPI0815784A2 (pt) Processo para a preparação de 1,2-propanodiol
EP2019118A4 (en) METHOD FOR SYNTHETIZING THYMOSINS
BRPI0807806A2 (pt) " processo para a fabricação de beta-miméticos ".
BRPI0815971A2 (pt) Processo para a preparação de 1,2-propanodiol
BRPI0719706A2 (pt) Processo para a preparação do 1,3-propanodiol.
ITMI20050801A1 (it) Procedimento per la preparazione di telmisartan
PT1812382E (pt) Processo para o fabrico de poli-isocianatos
EP2066640A4 (en) 2- (1-OXO-1H-ISOCHINOLIN-2-YL) ACETAMIDE DERIVATIVES
EP2050731A4 (en) PROCESS FOR PREPARING AROMATIC HYDROCARBONS
BRPI0914400A2 (pt) "processo para a síntese de um composto"
ZA201000394B (en) Process and intermediates for the synthesis of 1,2-substituted 3,4-dioxo-1-cyclobutene compounds
BRPI0816830A2 (pt) Processo para a preparação de derivados de 2,2-diflúor-etilamina por hidrogenação de amida
MA29092B1 (fr) Procédé de synthèse de salicylamides n-substitués

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.